TICKERNOMICS Sign up
Last Update: 2023-12-23 06:01:13
MATERIALISE NV ( MTLS ) https://www.materialise.com
6.73USD
Sector:
Technology
Industry:
Software-Application
Country:
Belgium
1y
3y
5y
10y
Historical Returns*:
SPY
23.45%
-22.20%
MTLS
SPY
30.72%
-88.55%
MTLS
SPY
112.82%
-66.01%
MTLS
SPY
201.04%
MTLS
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
373.31
318.59
0.17
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-67.19
1.41
1.49
-3.70
0.00
26.23
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
3.87
56.04
4.60
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
7.8344
0.36
0.80
0.96
Other Earnings and Cash Flow Stats:
MATERIALISE NV ( MTLS ) Net Income TTM ($MM) is -3.54
MATERIALISE NV ( MTLS ) Operating Income TTM ($MM) is 3.52
MATERIALISE NV ( MTLS ) Owners' Earnings Annual ($MM) is 0.00
MATERIALISE NV ( MTLS ) Current Price to Owners' Earnings ratio is 0.00
MATERIALISE NV ( MTLS ) EBITDA TTM ($MM) is 16.71
MATERIALISE NV ( MTLS ) EBITDA Margin is 4.60%
Capital Allocation:
MATERIALISE NV ( MTLS ) has paid 0.00 dividends per share and bought back 0.021000000000001 million shares in the past 12 months
MATERIALISE NV ( MTLS ) has reduced its debt by 15.2118032783 million USD in the last 12 months
Capital Structure:
MATERIALISE NV ( MTLS ) Interest-bearing Debt ($MM) as of last quarter is 86
MATERIALISE NV ( MTLS ) Annual Working Capital Investments ($MM) are -5
MATERIALISE NV ( MTLS ) Book Value ($MM) as of last quarter is 250
MATERIALISE NV ( MTLS ) Debt/Capital as of last quarter is 34%
Other Balance Sheet Stats:
MATERIALISE NV ( MTLS ) has 141 million in cash on hand as of last quarter
MATERIALISE NV ( MTLS ) has 98 million of liabilities due within 12 months, and long term debt 62 as of last quarter
MATERIALISE NV ( MTLS ) has 59 common shares outstanding as of last quarter
MATERIALISE NV ( MTLS ) has 0 million USD of preferred stock value
Academic Scores:
MATERIALISE NV ( MTLS ) Altman Z-Score is 2.29 as of last quarter
MATERIALISE NV ( MTLS ) Piotroski Score is 8.00 as of last quarter
Corporate Governance:
MATERIALISE NV ( MTLS ) largest shareholder is owning shares at 0.00 ($MM) value
(an insider) shares of MATERIALISE NV ( MTLS ) for the amount of $ on
4.17% of MATERIALISE NV ( MTLS ) is held by insiders, and 22.89% is held by institutions
MATERIALISE NV ( MTLS ) went public on 2014-06-25
Other MATERIALISE NV ( MTLS ) financial metrics:
FCF:-15.18
Unlevered Free Cash Flow:0.00
EPS:0.30
Operating Margin:3.87
Gross Profit Margin:56.04
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:6.98
Beta:0.96
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About MATERIALISE NV ( MTLS ) :
Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system partners. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.